Skin Laboratory PCL (BKK:SKIN) Notes Receivable: ฿0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SKIN Skin Laboratory PCL BKK:SKIN
20 GF Score
Price ฿0.88
! 2 Warning Signs
View Full Analysis

What is Skin Laboratory PCL Notes Receivable?

Skin Laboratory PCL BKK:SKIN +3.53% 20 Notes Receivable is ฿0.0 Mil as of Mar. 2026. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Skin Laboratory PCL's Notes Receivable for the quarter that ended in Mar. 2026 was ฿0.0 Mil.

Skin Laboratory PCL Notes Receivable Related Terms

Skin Laboratory PCL Notes Receivable Historical Data

* Premium members only.

The historical data trend for Skin Laboratory PCL's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Laboratory PCL Notes Receivable Chart

Skin Laboratory PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

Skin Laboratory PCL Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BKK:SKIN
20GF Score
Skin Laboratory PCL BKK:SKIN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skin Laboratory PCL Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ฿0.0 Mil mean?
Skin Laboratory PCL (BKK:SKIN) has a Notes Receivable of ฿0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Skin Laboratory PCL and its competitors.
Is Skin Laboratory PCL's Notes Receivable too high?
Skin Laboratory PCL's current Notes Receivable is ฿0.0 Mil. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's Notes Receivable compare to PG and CL?
Skin Laboratory PCL's Notes Receivable of ฿0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Skin Laboratory PCL and its competitors. Skin Laboratory PCL's current Notes Receivable is ฿0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current Notes Receivable of ฿0.0 Mil. The current Notes Receivable is ฿0.0 Mil. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current Notes Receivable is ฿0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Laboratory PCL Business Description

Address Unit P, Popular Road, No. 89, Cosmo Office Park Building, 8th Floor, Ban Mai Subdistrict, Pak Kret District, Nonthaburi, THA, 11120
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score

Get the complete analysis for BKK:SKIN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.88
Price